Khush F. Mehta Joins CardioDx as Chief Executive Officer

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Khush F. Mehta Joins CardioDx as Chief Executive Officer

REDWOOD CITY, CA--(Marketwired - Jun 1, 2016) - CardioDx, Inc. , a molecular diagnostics company specializing in cardiovascular genomics , announced today the appointment of Khush Mehta as President, Chief Executive Officer, and a member of the Board of Directors of CardioDx. With a proven track record for commercial success and execution in the global healthcare industry, Mehta will help drive the organization to the next level of commercial growth, value creation for its stakeholders, and the expansion of the company's product portfolio through innovation and partnerships. He will focus on overseeing the day-to-day operations and accelerating profitable growth in the near and long-term. As CEO, Mehta succeeds David Levison, who has been named the Chief Strategy Officer of the company.

With more than 20 years in the healthcare industry, Mehta brings a wealth of experience in strategic business development and operations to CardioDx. Prior to joining CardioDx, he served as the Global Head of the Healthcare Enterprise Solutions at Siemens. Mehta has also held additional executive leadership roles at Siemens Healthcare, including Chief Strategy Officer and Head of Siemens Healthcare Asia Pacific. He earned a Bachelor and a Master of Commerce and Economics at the Sydenham College of Commerce and Economics in Mumbai, India along with a Master of Business Administration in competitive strategies and international finance from Yale University.

"This is an exciting time of change within healthcare. Khush is a proven leader with a track record for execution, clear business vision, and a demonstrated record for driving growth and profitability for companies," said Ajit Singh, Chairman of the Board. "With his extensive years of leadership experience, Khush has a deep understanding of the global healthcare marketplace and its supply chain, and possesses strong operational acumen to drive commercial success in the U.S. and international markets. Having worked with Khush previously, I know that his skills will accelerate the next phase of expanded growth and innovation."

"I am honored and excited to lead CardioDx in advancing the commercialization of the Corus CAD test during this transformational time within the healthcare industry," said Khush Mehta, Chief Executive Officer of CardioDx. "The PROMISE trial substudy recently presented at the 65th American College of Cardiology Annual Scientific Meeting further underscored the science behind our test that gives physicians an effective solution for clinical decision-making for obstructive coronary artery disease. 1 I look forward to working with the entire CardioDx team as we embark on this journey for improving the quality of cardiovascular care."

As the Chief Strategy Officer, Levison, the founder of CardioDx, will lead the company in business development, health payer coverage, and next generation technology. "Since the company was founded in 2004, CardioDx has had a strong commitment to improving healthcare quality and efficiency through genomic technologies and expanding patient access to new diagnostic tests that provide precision medicine in cardiovascular medicine," said David Levison, Chief Strategy Officer of CardioDx. "With that continued promise, I am excited to focus my attention in the clinical and genomic diagnostics space and look forward to supporting further expanded patient access and the delivery of next generation products to patients worldwide."

"I am very pleased that David will continue to add his industry knowledge and expertise as we embark on the next phase of growth. As the Founder and CEO, his leadership for more than a decade has taken the company from concept to having served more than 175,000 patients and thousands of clinicians in a dynamic healthcare environment. We are grateful to David's dedication to the organization, and I look forward to his future contributions," said Ajit Singh.

About Obstructive Coronary Artery Disease Coronary artery disease (CAD) is a very common heart condition in the United States. One in seven deaths among Americans is caused by CAD. 2 CAD can cause a narrowing or blockage of the coronary arteries (vessels to the heart that supply the heart with blood, oxygen, and nutrients), reducing blood flow to the heart muscle. This narrowing or blockage in the coronary arteries is often referred to as obstructive CAD, characterized by the presence of atherosclerosis, or plaque.

About the Corus CAD Test Corus CAD is the first and only commercially available blood test that can safely and conveniently help primary care clinicians and cardiologists assess whether or not a stable non-diabetic patient's symptoms may be due to obstructive coronary artery disease. The test incorporates age, sex and gene expression measurements into a single score that indicates the likelihood of obstructive CAD. Clinicians use the Corus CAD score, along with other clinical information, to determine whether further cardiac testing is necessary, which can help patients avoid unnecessary exposure to radiation associated with medical imaging testing, as well as possible reactions to imaging dyes and/or potential complications from invasive cardiac tests requiring catheterization. The test involves a routine blood draw that is conveniently administered in the clinician's office or clinical laboratory patient service center. The Corus CAD test is the only sex-specific test for the evaluation of obstructive CAD because it accounts for cardiovascular differences between men and women.

The test has been clinically validated in independent male and female patient cohorts, including two prospective, multicenter U.S. studies, PREDICT and COMPASS. 3,4 In the COMPASS study, the Corus CAD test outperformed myocardial perfusion imaging (MPI) as a diagnostic tool to exclude obstructive CAD by demonstrating a higher negative predictive value (96% vs. 88%, p < 0.001) than MPI for assessing the presence of obstructive CAD. 5 To date, more than 150,000 Corus CAD test results have been provided to clinicians. CardioDx processes all Corus CAD test samples at its CLIA-certified and CAP-accredited clinical laboratory in Redwood City, California.

The Corus CAD test has been recognized by The Wall Street Journal 's Technology Innovation Awards, honored as a Gold Edison Award recipient, and named one of TIME 's Top 10 Medical Breakthroughs.

About CardioDx CardioDx, Inc., a molecular diagnostics company specializing in cardiovascular genomics, is committed to developing clinically validated tests that empower clinicians to better tailor care to each individual patient. Strategically focused on coronary artery disease, CardioDx is committed to expanding patient access and improving healthcare quality and efficiency through the commercialization of genomic technologies. Please visit www.cardiodx.com for additional information.

* Obstructive CAD is defined as at least one atherosclerotic plaque causing ≥ 50% luminal diameter stenosis in a major coronary artery ( ≥ 1.5 mm lumen diameter) as determined by invasive quantitative coronary angiography (QCA) or coronary computed tomography angiography (CTA) ( ≥ 2.0 mm). References 1 Voora D, Coles A, Lee K, et al. An Age- and Sex-specific Peripheral Blood Gene Expression Score Correlates with Future Cardiovascular Events: Insights from the PROMISE trial. J Am Coll Cardiol . 2016; 67(13_S):2094-2094. 2 Mozaffarian D, Benjamin EJ, Go AS, et al. On Behalf of the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart Disease and Stroke Statistics - 2015 Update: A Report from the American Heart Association. Circulation . 2015;131(4):e29-e322. 3 Rosenberg S, Elashoff MR, Beineke P, et al. Multicenter Validation of the Diagnostic Accuracy of a Blood-Based Gene Expression Test for Assessing Obstructive Coronary Artery Disease in Nondiabetic Patients. Ann Intern Med . 2010;153:425-434. 4 Thomas GS, Voros S, McPherson JA, et al. A Blood-Based Gene Expression Test for Obstructive Coronary Artery Disease Tested in Symptomatic Nondiabetic Patients Referred for Myocardial Perfusion Imaging: The COMPASS Study. Circ Cardiovasc Genet . 2013;6(2):154-162. 5 The COMPASS study demonstrated that the Corus CAD algorithm has an NPV of 96% at the pre-specified threshold of 15 in a population of men and women referred to MPI.

For media inquiries, please contact Kelly Laban Lazar Partners klaban@lazarpartners.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

A&G Management's Bold New Era with WPM Partnership

Updated Category News Views 6

Shaking Up Baltimore's Real Estate Scene Swapping up management partners can be a dicey game, but A&G Management seems to be pulling it off without a hitch. As of January 4, 2027, WPM Real Estate Management will take over the reins for more than 3,000 apartment homes scattered across Anne Arundel, Howard, and Baltimore counties. A new set of hands is stepping in for...

Continue Reading
Sungrow's Keeper Family: Revolutionizing C&I Energy Storage

Updated Category News Views 109

The Next Level in Energy Storage Solutions Well, folks, Sungrow's got something up its sleeve that's shaking up the energy storage scene. They're calling it the 'Keeper Family,' and if you’re deep into commercial and industrial (C&I) energy storage, this might just be your ticket to topping those profit charts. Launched at the Global Energy Pioneer Summit 2026, their...

Continue Reading
Gary Brecka's Longevity Centers Set to Launch with Impact

Updated Category News Views 84

A Footprint of Longevity in the Making It's not every day you see a name like Daymond John, of Shark Tank fame, getting his hands into the business of human longevity. But here we are, with Gary Brecka's Ultimate Longevity Center (ULC) getting ready to open its first centers come January 2027, in Arizona, Colorado, Florida, and Southern California. More than 300 U.S....

Continue Reading
Nevada Expands Rural Youth Mental Health Access

Updated Category News Views 129

Nevada's Rural Mental Health Crisis When you're navigating the barren stretches of rural Nevada, the scenic views can be breathtaking. But for many families, finding basic services like mental health care is as challenging as striking water in the desert. Cartwheel Care has taken the bull by the horns with their latest initiative to bridge this glaring gap. Partnering...

Continue Reading
China's APEC Summit: A Catalyst for Business Growth?

Updated Category News Views 92

A Shift Toward Regional Stability China's position as this year's APEC rotating chair presents both opportunity and challenge as economies grapple with trade barriers and technological upheaval. The 33rd APEC Economic Leaders' Meeting in Shenzhen is intended to navigate these turbulent waters, setting the stage for a more stable regional environment. APEC's Role in...

Continue Reading
Bizzdesign Tops Gartner’s 2026 Enterprise Architecture List

Updated Category News Views 78

Enterprise Architecture’s Silent Backbone Sometimes it's the quiet operators like Bizzdesign that hijack the spotlight after years of steady steering. With the latest nod from Gartner, Bizzdesign is clearly on a tear in the enterprise architecture domain. In their 2026 Critical Capabilities report, Bizzdesign's products—Horizzon, Alfabet, and Hopex—secured top spots...

Continue Reading
SOBER CAFFEINE™: Modern Energizer Without the Bull

Updated Category News Views 135

Shed the Cans and Embrace Convenience I'm sure you've had a run-in with the standard energy drink routine. You know, the massive cans, a gut punch of sugar, and the inevitable crash that follows? Sobriety Supplements LLC decided enough is enough and rolled out something that just makes sense—SOBER CAFFEINE™ capsules. This little pill is a godsend for folks sick of...

Continue Reading
WHP Global's Japan Move: A Major Toy Market Play

Updated Category News Views 20

New Horizons for Toys"R"Us in Japan Well, folks, look who's back in the toy game with a vengeance! WHP Global is shaking hands with Pan Pacific International Holdings (PPIH) to breathe new life into Toys"R"Us across Japan. Now PPIH isn’t just any player. We're talking about Japan's fourth-largest retailer, helming giants like Don Quijote and aiming to crown itself as...

Continue Reading
Christian Faith: Navigating Spiritual Pitfalls Wisely

Updated Category News Views 74

Taking a Deep Look at Christian Faith If you think faith is as simple as saying a few prayers and checking church attendance off the list, well, think again. G. Joseph Johnson, in his thought-provoking tome "Roads, Ditches, Traps, and Snares," believes that faith is a journey filled with twists, turns, and yes, a few traps. This book is a sort of roadmap for Christians,...

Continue Reading
Mall of America Strives for World Record This Black Friday

Updated Category News Views 128

History in the Making at Mall of America Yeah, it seems these folks are not just about shopping anymore. The Mall of America is aiming to set the bar high this Black Friday, eyeing a GUINNESS WORLD RECORDS title for the most people holding up the same shopping bag all at once. Imagine a thousand people, synchronized like a flash mob—only with shopping bags instead of...

Continue Reading

Top 5 Most Recently Viewed Articles

AEX Index Climbs as Technology Sector Shines Bright

Updated Category News Views 246

AEX Index Climbs as Technology Sector Shines Bright The AEX index in the Netherlands showcased a remarkable performance following gains across multiple sectors during a recent trading session. The technology, consumer goods, and consumer services sectors were significant contributors to this upward trend, reflecting the overall market optimism. Market Performance Overview...

Continue Reading
Comoto Partners with Motorcycle Industry Council to Boost Riding

Updated Category News Views 337

Comoto and the MIC Collaborate for Motorcycling Growth The Comoto Family of Brands, which includes names like Cycle Gear, RevZilla, and J&P Cycles, has recently announced an exciting partnership with the Motorcycle Industry Council (MIC). This collaboration aims to ignite the passion for motorcycle riding among new and potential riders through innovative educational...

Continue Reading
Oxford Treatment Center Launches Evening Addiction Services

Updated Category News Views 288

Oxford Treatment Center Enhances Addiction Care Availability Oxford Treatment Center is excited to announce the launch of its new evening intensive outpatient program (IOP), designed specifically for those in Southaven seeking flexible addiction care. This initiative addresses a crucial gap in services for individuals juggling daytime obligations, such as work or school,...

Continue Reading
Anticipating Earnings: Insights for MeridianLink (MLNK)

Updated Category News Views 146

MeridianLink's Earnings Outlook MeridianLink (NYSE: MLNK) is gearing up to announce its quarterly earnings soon, which has investors excited about what lies ahead. As the moment approaches, there are critical factors that stakeholders should consider to navigate the upcoming report effectively. Anticipated Earnings Analysis Expectations are set for MeridianLink to unveil...

Continue Reading
BCT - The Community's Bank Celebrates Loudoun's Favorite Honors

Updated Category News Views 145

BCT - The Community's Bank Wins Loudoun's Favorite Awards BCT - The Community's Bank has been recognized by residents as one of Loudoun's Favorite banks, having won multiple awards in the recent annual reader's poll. This recognition reflects the bank's unwavering dedication to providing top-notch financial services to its local community. For the second consecutive year,...

Continue Reading